Syndax Pharmaceuticals (SNDX) Q2 2025 Earnings

5MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.25
-1.1
-0.95
-0.8

Details

Expected EPS
-1.252412
Actual EPS
-0.98
Surprise EPS
0.27
Surprise Percent
+21.75%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -0.98 per share for Q2 2025.

0 Comments

Share your thoughts